Yasir B. Al-Wakeel
2015
In 2015, Yasir B. Al-Wakeel earned a total compensation of $2.3M as Former Chief Financial Officer and Head of Corporate Development at Merrimack Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $129,500 |
| Option Awards | $1,820,880 |
| Salary | $145,002 |
| Other | $90,017 |
| Total | $2,285,399 |
Al-Wakeel received $1.8M in option awards, accounting for 80% of the total pay in 2015.
Al-Wakeel also received $100K in bonus, $129.5K in non-equity incentive plan, $145K in salary and $90K in other compensation.
Rankings
In 2015, Yasir B. Al-Wakeel's compensation ranked 4,211th out of 13,638 executives tracked by ExecPay. In other words, Al-Wakeel earned more than 69.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,211 out of 13,638 | 69th |
Division Manufacturing | 1,542 out of 5,190 | 70th |
Major group Chemicals And Allied Products | 561 out of 1,854 | 70th |
Industry group Drugs | 444 out of 1,528 | 71st |
Industry Pharmaceutical Preparations | 349 out of 1,182 | 71st |
Source: SEC filing on June 26, 2017.
Al-Wakeel's colleagues
We found four more compensation records of executives who worked with Yasir B. Al-Wakeel at Merrimack Pharmaceuticals in 2015.
2015
Robert Mulroy
Merrimack Pharmaceuticals
Chief Executive Officer
2015
Peter Laivins
Merrimack Pharmaceuticals
Former Head of Development
2015
William McClements
Merrimack Pharmaceuticals
Former Head of Corporate Operations
2015
Edward Stewart
Merrimack Pharmaceuticals